|Bid||0.4550 x 0|
|Ask||0.4600 x 0|
|Day's Range||0.4100 - 0.4600|
|52 Week Range||0.3000 - 1.3200|
|Beta (5Y Monthly)||1.96|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 01, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.25|
* First prescriptions for Khiron's medical cannabis in Peru are filled as the Company surpasses 3,000 medical cannabis prescription milestone in Colombia * Khiron becomes the first Company to sell and fill medical cannabis prescriptions through private pharmacies in Peru * The Company began sales in Peru with full spectrum High CBD supplied by Khiron Colombia and distributed to patients under the previously announced agreement with Farmacia Universal S. * Farmacia Universal is an established pharmacy chain, with 10 locations in Lima * Quotas for Khiron's high THC medical cannabis have also been approved by DIGEMID, Peru's drug regulatory authority, with first prescriptions anticipated in Q4 2020 * With a population of 32 million, Peru's medical cannabis market is expected to be one of the largest in Latin AmericaTORONTO, Sept.
), for the domestic market of Colombia and for export of finished products * Certification demonstrates not only the Government of Colombia's commitment to the medical cannabis industry in Colombia, but also its support of Khiron's business plan to create value added products in the medical and CPG cannabis industry for domestic market and for export * Khiron is one of three companies to obtain this status, placing the Company at the forefront of the industry in ColombiaTORONTO, Sept. 22, 2020 /CNW/ - Khiron Life Sciences Corp.
Foundation also announces three Global Goals award winners and launches two innovative partnerships to address COVID-19 impacts in KenyaSEATTLE, Sept. 21, 2020 /CNW/ -- The Bill & Melinda Gates Foundation today named Dr.